Paclitaxel Enhances Therapeutic Efficacy of the F8-Il2 Immunocytokine to EDA-Fibronectin-Positive Metastatic Human Melanoma Xenografts

Cancer Research - United States
doi 10.1158/0008-5472.can-11-1919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Immunogenicity of the Hu14.18-Il2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Human Fibronectin Contains Distinct Adhesion- And Motility-Promoting Domains for Metastatic Melanoma Cells

Journal of Cell Biology
MedicineCell Biology
1986English

Overexpression of Heat Shock Transcription Factor 1 Enhances the Resistance of Melanoma Cells to Doxorubicin and Paclitaxel

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Superior Efficacy of Trimelamol to Hexamethylmelamine in Human Ovarian Cancer Xenografts

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
1986English

Association of Gender With Efficacy of Immunotherapy in Metastatic Melanoma

Journal of Immunological Sciences
2019English

Nanoparticle Modulation of the Tumor Microenvironment Enhances Therapeutic Efficacy of Cisplatin

Journal of Controlled Release
Pharmaceutical Science
2015English

Modulation of Cell-Adhesive Activity of Fibronectin by the Alternatively Spliced EDA Segment

Journal of Cell Biology
MedicineCell Biology
1997English

Preclinical Characterization of DEKAVIL (F8-Il10), a Novel Clinical-Stage Immunocytokine Which Inhibits the Progression of Collagen-Induced Arthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2009English

Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy